Quantifying brain development in the HEALthy Brain and Child Development (HBCD) Study: The magnetic resonance imaging and spectroscopy protocol

By sjmartinez • September 29, 2024

Dean DC 3rd, Tisdall MD, Wisnowski JL, Feczko E, Gagoski B, Alexander AL, Edden RAE, Gao W, Hendrickson TJ, Howell BR, Huang H, Humphreys KL, Riggins T, Sylvester CM, Weldon KB, Yacoub E, Ahtam B, Beck N, Banerjee S, Boroday S, Caprihan A, Caron B, Carpenter S, Chang Y, Chung AW, Cieslak M, Clarke WT, Dale A, Das S, Davies-Jenkins CW, Dufford AJ, Evans AC, Fesselier L, Ganji SK, Gilbert G, Graham AM, Gudmundson AT, Macgregor-Hannah M, Harms MP, Hilbert T, Hui SCN, Irfanoglu MO, Kecskemeti S, Kober T, Kuperman JM, Lamichhane B, Landman BA, Lecour-Bourcher X, Lee EG, Li X, MacIntyre L, Madjar C, Manhard MK, Mayer AR, Mehta K, Moore LA, Murali-Manohar S, Navarro C, Nebel MB, Newman SD, Newton AT, Noeske R, Norton ES, Oeltzschner G, Ongaro-Carcy R, Ou X, Ouyang M, Parrish TB, Pekar JJ, Pengo T, Pierpaoli C, Poldrack RA, Rajagopalan V, Rettmann DW, Rioux P, Rosenberg JT, Salo T, Satterthwaite TD, Scott LS, Shin E, Simegn G, Simmons WK, Song Y, Tikalsky BJ, Tkach J, van Zijl PCM, Vannest J, Versluis M, Zhao Y, Zöllner HJ, Fair DA, Smyser CD, Elison JT; HBCD MRI Working Group. Quantifying brain development in the HEALthy Brain and Child Development (HBCD) Study: The magnetic resonance imaging and spectroscopy protocol. Dev Cogn Neurosci. 2024 Sep 21;70:101452. doi: 10.1016/j.dcn.2024.101452. Epub ahead of print. PMID: 39341120.

Tags: Cedars Sinai DoM, development, HBCD, infant, MRI, MRS, protocol, Publications

Related Posts

Psychotherapy vs antidepressants in heart failure: Impact of adherence

IsHak WW, Hamilton MA, Diniz MA, Mirocha J, Chernoff R, Hedrick R, Aronow H, Darwish T, Messineo G, Pasini M, Olanisa L, Tetrault E, Arun[...]

Association of Eicosanoids and Eicosanoid-Related Metabolites With Obesity and Cardiometabolic Traits

Chitsazan M, Parekh JK, Grundmann AL, Lau ES, Alotaibi M, Yu B, Rebholz CM, Selvin E, Allen NB, Allison MA, Jain M, Cheng S, Ho[...]

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial

Baden LR, Shah NS, Liu STH, Cohen J, Moy J, Kumar A, McComsey GA, Chen P, Floris-Moore M, Singer NG, Fernandez I, Slandzicki AJ, Wiley[...]